ArticlePDF Available

Full genome sequence of the first SARS-CoV-2 detected in Mexico

Authors:
  • Public Health Laboratory Ministry of Health

Abstract

SARS-CoV-2 was first detected in the city of Wuhan, Hubei Province, China. In this report, we describe the complete genome sequence of the first imported SARS-CoV-2, detected in a Mexican patient who had traveled to Bergamo, Italy. Phylogenetic analysis showed that this isolate belongs to subclade A2a (lineage G) and is closely related to isolates from Finland, Germany and Brazil, all of which were from patients with a history of travel to Italy. This is the first report of the complete genome sequence of this virus in Mexico.
Vol.:(0123456789)
1 3
Archives of Virology
https://doi.org/10.1007/s00705-020-04695-3
ANNOTATED SEQUENCE RECORD
Full genome sequence oftherst SARS‑CoV‑2 detected inMexico
FabiolaGarcés‑Ayala1· AdnanAraiza‑Rodríguez1· EdgarMendieta‑Condado1·
AbrilPaulinaRodríguez‑Maldonado1· ClaudiaWong‑Arámbula1· MagalyLanda‑Flores1·
JuanCarlosdelMazo‑López1· MaribelGonzález‑Villa1· NoéEscobar‑Escamilla1 · DavidEsaúFragoso‑Fonseca1 ·
Maríadel CarmenEsteban‑Valencia1· LourdesLloret‑Sánchez1· DayaniraSarithArellano‑Suarez1·
TatianaErnestinaNuñez‑García1· NervainBenjaminContreras‑González1· NatividadCruz‑Ortiz1·
AdrianaRuiz‑López1· MiguelÁngelFierro‑Valdez1· DanielRegalado‑Santiago1· NancyMartínez‑Velázquez1·
MireyaMederos‑Michel1· JoelVázquez‑Pérez2· JoséArturoMartínez‑Orozco2· EduardoBecerril‑Vargas2·
JorgeSalas2· LucíaHernández‑Rivas1· IrmaLópez‑Martínez1· JoséLuisAlomía‑Zegarra3· HugoLópez‑Gatell4·
GiselaBarrera‑Badillo1 · JoséErnestoRamírez‑González1
Received: 16 March 2020 / Accepted: 11 May 2020
© Springer-Verlag GmbH Austria, part of Springer Nature 2020
Abstract
SARS-CoV-2 was first detected in the city of Wuhan, Hubei Province, China. In this report, we describe the complete genome
sequence of the first imported SARS-CoV-2, detected in a Mexican patient who had traveled to Bergamo, Italy. Phylogenetic
analysis showed that this isolate belongs to subclade A2a (lineage G) and is closely related to isolates from Finland, Germany
and Brazil, all of which were from patients with a history of travel to Italy. This is the first report of the complete genome
sequence of this virus in Mexico.
Virus name: hCoV/Mexico/CDMX/InDRE_01/2020
GISAID accession ID: EPI_ISL_412972
A novel coronavirus, recently named severe acute respiratory
syndrome-related coronavirus type 2 (SARS-CoV-2), was
identified in the city of Wuhan, Hubei Province, China, in
December of 2019 It is betacoronavirus that affects the lower
respiratory tract and manifests as pneumonia in humans [1,
2]. According to the Johns Hopkins University Coronavi-
rus Resource Center and the Daily Technical Statement on
New Coronavirus Cases Worldwide (COVID-19) issued by
the Secretary of Health of Mexico, as of March 20, 2020,
234,072 confirmed cases have been reported worldwide with
9840 deaths. In Mexico, 203 cases have been confirmed,
with two deaths reported [3, 4]. At the time of this writ-
ing, 768 complete genomic sequences of SARS Cov-2 have
been obtained and deposited in the GISAID database, and
10 clades have been defined from phylogenetic studies car-
ried out with these sequences (A1, A1a, A2, A2a, A3, A5,
B, B1, B2 and B4) [5].
Here, we report the complete genome sequence of SARS-
CoV-2 from the first imported case of COVID-19 detected in
Mexico. The sample hCoV/Mexico/CDMX/InDRE_01/2020
was obtained directly from a nasopharyngeal swab from a
35-year-old male patient (InDRE 1198) residing in Mex-
ico City who had a confirmed diagnosis of SARS-CoV-2
on February 27, 2020 and had traveled to Bergamo, Italy,
between February 16 and 22, 2020.
A diagnostic test for COVID-19 was first conducted
at the Instituto Nacional de Enfermedades Respiratorias,
Mexico City, on February 27, 2020. Following the national
guidelines of the Mexican Ministry of Health [6], a sample
was sent to the National Influenza Center at the Instituto
de Diagnostico y Referencia Epidemiologicos (InDRE); the
Handling Editor: Yue Wang.
* Gisela Barrera-Badillo
gisela.barrera20@yahoo.com.mx
* José Ernesto Ramírez-González
ernesto.ramirez@salud.gob.mx
1 Instituto de Diagnóstico y Referencia Epidemiológicos “Dr.
Manuel Martínez Báez”, MexicoCity, Mexico
2 Instituto Nacional de Enfermedades Respiratorias,
MexicoCity, Mexico
3 Dirección General de Epidemiología, MexicoCity, Mexico
4 Subsecretaría de Prevención y Promoción de la Salud,
MexicoCity, Mexico
F. Garcés-Ayala etal.
1 3
confirmatory diagnosis was conducted using a real-time RT-
PCR protocol to detect SARS-CoV-2 [7], and of a 221-bp
fragment of the region coding for the orf1ab polyprotein
was sequenced by the Sanger method and will be published
elsewhere. The sample from the patient had a cycle threshold
value of 19.5 for the E gene and 20.4 for the RdRP gene.
The complete virus genome from the positive case was
amplified using the novel coronavirus sequencing multiplex
primers [8] (https ://artic .netwo rk/ncov-2019). cDNA syn-
thesis was conducted using Super Script IV Reverse Tran-
scriptase (Invitrogen) and the concentration of PCR the
product was measured using a Qubit dsDNA High Sensitiv-
ity Kit on a Qubit 3.0 fluorometer (Thermo Fisher) and an
Agilent 2100 Bioanalyzer (Agilent Technologies).
A library without barcodes was generated and
sequenced using an Ion Torrent system, using an Ion
Xpress™ Plus Fragment Library Kit for sequencing on
an Ion 318™ v2 chip. A total of 1,445,751 reads were
obtained for hCov/Mexico/CDMX/InDRE_01/2020. The
complete genome sequence was assembled using CLC
Genomics Workbench 20 (QIAGEN) and SPAdes [9] and
mapped against the reference sequence Wuhan-Hu-1 (Gen-
Bank accession number NC_045512.2).
The consensus sequence was assembled into a single
contig with a total length of 29,849 bp, corresponding to
99.8% of genome, and a deep average coverage of 3,983X.
The sequence was deposited in the GISAID database [5]
under accession ID EPI_ISL_412972.
A database was constructed including 178 genomic
sequences available on the GISAID platform, obtained
from December 31, 2019 to March 05, 2020, reported
in 22 countries. A phylogenetic tree was constructed in
MEGA 6 software using the neighbor-joining method and
the Kimura 2-parameter evolution model with 100 boot-
strap replicates [10]. The strain hCoV/Mexico/CDMX/
InDRE_01/2020 was grouped in the clade A2 subclade
A2a (also called lineage G) and is closely related to iso-
lates from Finland, Italy, and Germany as well as an iso-
late from the first imported SARS-CoV-2 case in Brazil
[11] (Fig.1).
Fig. 1 Neighbor-joining tree constructed in MEGA using the Kimura
2-parameter evolution model with 100 bootstrap replicates. hCoV/
Mexico/CDMX/InDRE_01/2020 (indicated by an arrow) is grouped
in clade A2a with sequences previously reported from Brazil, Ger-
many, Italy, and Finland. The 14408C>T substitution is characteristic
of subclade A2a
Genome sequence of the first SARS-CoV-2 detected in Mexico
1 3
Genetic analysis showed that the hCoV/Mexico/CDMX/
InDRE_01/2020 genome differs by seven nucleotide sub-
stitutions compared to the Wuhan-Hu-1 reference strain:
241C>T, 3037C>T, 14408C>T, 23403A>G, 28881G>A,
28882G>A, and 28883G>C. We confirmed the presence of
the 14408C>T substitution, which is characteristic of the
sequences clustered in subclade A2a.
A second database of 768 sequences deposited until
March 20, 2020, was used to construct a phylogenetic
tree. This analysis showed that hCoV/Mexico/CDMX/
InDRE_01/2020 clusters with European lineage G
sequences, mainly from Belgium, Switzerland, and Eng-
land (Fig.2). This finding correlates with the transmission
events reported by GISAID [5], which suggest that this strain
was first introduced into Belgium, then England, and finally,
Italy, where the Mexican patient had been traveling.
This is the first report of the complete genome of this
virus in our country, and these data will contribute to the
molecular epidemiology of the SARS-CoV-2.
Acknowledgements We thank all the staff of the Technological Devel-
opment and Molecular Research Unit (Susana Serrano, Lidia García,
Estela Corona, América Mandujano, Araceli Rodríguez, Isaura Mar-
tinez, Elizabeth Andrade, Juan Luis Tellez Mario Torres, Claudia
Gómez, Guadalupe Montiel, Aída García), Virology Department, and
Sample Control and Services Department at InDRE for technical assis-
tance; we also thank Blanca Taboada for bioinformatical assistance,
and Nuno Faria for sharing multiplex primers. No external funding
was received for this work.
The findings and conclusions in this report are those of the authors
and do not necessarily represent the official opinion of the Ministry of
Health of Mexico.
Funding None.
Compliance with ethical standards
Conflict of interest The authors declare no conflict of interest.
Ethical approval This article does not contain any studies with human
participants or animals performed by any of the authors.
References
1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan
G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X,
Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G,
Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of
patients infected with 2019 novel coronavirus in Wuhan, China.
Lancet 395(10223):497–506. https ://doi.org/10.1016/s0140
-6736(20)30183 -5
2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J etal (2020) A
novel coronavirus from patients with pneumonia in China, 2019.
N Engl J Med 382:727–733. https ://doi.org/10.1056/nejmo a2001
017
3. Secretaria de Salud (2020) Comunicado Técnico Diario Nuevo
Coronavirus en el Mundo (COVID-19). 2020, March 20. https ://
www.gob.mx/cms/uploa ds/attac hment /file/54259 9/Comun icado
_Tecni co_Diari o_COVID -19_2020.03.20.pdf. Accessed 20 Mar
2020
4. Coronavirus Resource Center Johns Hopkins University. 2020.
https ://coron aviru s.jhu.edu/. Accessed 20 Mar 2020
5. Global Initiative on Sharing All Influenza Data. 2020. https ://
www.gisai d.org/epifl u-appli catio ns/next-sars-cov2-app/. Accessed
20 Mar 2020
6. Secretaría de Salud. Lineamiento Estandarizado para la Vigi-
lancia Epidemiológica y por Laboratorio de Enfermedad por
hCoV-19/Netherlands/Helmond 1363548/2020|EPI ISL 413574|2020-02-29
hCoV-19/Switzerland/GE1422/2020|EPI ISL 415454|2020-02-28
hCoV-19/Switzerland/AG7120/2020|EPI ISL 415457|2020-02-29
hCoV-19/Switzerland/GE1402/2020|EPI ISL 415700|2020-02-28
hCoV-19/Switzerland/VD5615/2020|EPI ISL 414023|2020-03-01
hCoV-19/Switzerland/VD0503/2020|EPI ISL 415459|2020-02-29
hCoV-19/Switzerland/TI2045/2020|EPI ISL 415703|2020-03-01
hCoV-19/Switzerland/GR2988/2020|EPI ISL 415698|2020-02-27
hCoV-19/Switzerland/GR3043/2020|EPI ISL 415699|2020-02-27
hCoV-19/Mexico/CDMX-InDRE 01/2020|EPI ISL 412972|2020-02-27
hCoV-19/England/20099038206/2020|EPI ISL 415129|2020-02-29
hCoV-19/Switzerland/1000477757/2020|EPI ISL 413021|2020-02-29
hCoV-19/Brazil/SPBR-12/2020|EPI ISL 416034|2020-03-04
hCoV-19/Germany/Baden-Wuerttemberg-1/2020|EPI ISL 412912|2020-02-25
hCoV-19/Switzerland/1000477796/2020|EPI ISL 413022|2020-02-29
hCoV-19/England/200990723/2020|EPI ISL 414012|2020-02-27
hCoV-19/Peru/010/2020|EPI ISL 415787|2020-03-10
hCoV-19/Switzerland/GE3895/2020|EPI ISL 413997|2020-02-26
hCoV-19/Switzerland/BL0902/2020|EPI ISL 414021|2020-02-27
hCoV-19/Switzerland/BE6651/2020|EPI ISL 415456|2020-02-29
hCoV-19/Switzerland/BS0914/2020|EPI ISL 415701|2020-03-02
hCoV-19/Switzerland/1000477806/2020|EPI ISL 413024|2020-02-29
hCoV-19/Switzerland/GE0199/2020|EPI ISL 415455|2020-02-28
hCoV-19/Switzerland/GE9586/2020|EPI ISL 414022|2020-02-27
hCoV-19/Netherlands/NoordHolland 2/2020|EPI ISL 414549|2020-03-03
hCoV-19/Belgium/QKJ-03015/2020|EPI ISL 415158|2020-03-01
hCoV-19/Belgium/BC-03016/2020|EPI ISL 415157|2020-03-01
Fig. 2 Neighbor-joining tree constructed with 768 sequences avail-
able in the GISAID database on March 20, 2020. The analysis shows
that the Mexican strain (indicated by an arrow) clusters with Euro-
pean sequences, corroborating the transmission events reported by
GISAID (Belgium-Germany-Italy-Mexico) for this first imported case
in our country
F. Garcés-Ayala etal.
1 3
COVID-2019. https ://www.gob.mx/cms/uploa ds/attac hment /
file/53794 4/Linea mient o_COVID -19_2020.02.27.pdf. Accessed
29 Feb 2020
7. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu
DKW, Bleicker T, Brünink S, Schneider J, Schmidt ML, Mulders
D, Haagmans BL, van der Veer B, van den Brink S, Wijsman L,
Goderski G, Romette JL, Ellis J, Zambon M, Peiris M, Goossens
H, Reusken C, Koopmans MPG, Drosten C (2020) Detection of
2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro
Surveill. https ://doi.org/10.2807/1560-7917.es.2020.25.3.20000 45
8. Artic Network n-CoV 2019. https ://artic .netwo rk/ncov-2019.
Accessed 22 Jan 2020
9. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M,
Kulikov AS, Lesin VM, Nikolenko SI, Pham S, Prjibelski AD,
Pyshkin AV, Sirotkin AV, Vyahhi N, Tesler G, Alekseyev MA,
Pevzner PA (2012) SPAdes: a new genome assembly algorithm
and its applications to single-cell sequencing. J Comput Biol
19(5):455–477. https ://doi.org/10.1089/cmb.2012.0021
10. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S (2013)
MEGA6: molecular evolutionary genetics analysis version 6.0.
Mol Biol Evol 30(12):2725–2729. https ://doi.org/10.1093/molbe
v/mst19 7
11. First Report of Covid-19 in south America. http://virol ogica l.org/t/
first -repor t-of-covid -19-in-south -ameri ca/409. Accessed 29 Feb
2020
Publisher’s Note Springer Nature remains neutral with regard to
jurisdictional claims in published maps and institutional affiliations.
... The first SARS-CoV-2 genome reported from a Mexican patient was published in May 2020 and belonged to the subclade A2a, lineage G (Garceś-Ayala et al., 2020). An initial genomic analysis from 17 whole genome SARS-CoV-2 sequences isolated from Mexican patients reported the presence of the H49Y aa substitution in the Spike protein and the phylogenetic analysis showed that the viruses sequenced belonged to the A2/G and B/S lineages, two of the three lineages circulating at that time (Taboada et al., 2020). ...
... During the pandemic, SARS-CoV-2 variants have undergone extensive evolutionary transitions and ultimately achieved global dominance (Telenti et al., 2022). In Mexico, the first case of SARS-CoV-2 was reported on 28 February 2020 (Garceś-Ayala et al., 2020) 2021;Taboada et al., 2021). ...
Article
Full-text available
Background The SARS-CoV-2 virus has caused unprecedented mortality since its emergence in late 2019. The continuous evolution of the viral genome through the concerted action of mutational forces has produced distinct variants that became dominant, challenging human immunity and vaccine development. Aim and methods In this work, through an integrative genomic approach, we describe the molecular transition of SARS-CoV-2 by analyzing the viral whole genome sequences from 50 critical COVID-19 patients recruited during the first year of the pandemic in Mexico City. Results Our results revealed differential levels of the evolutionary forces across the genome and specific mutational processes that have shaped the first two epidemiological waves of the pandemic in Mexico. Through phylogenetic analyses, we observed a genomic transition in the circulating SARS-CoV-2 genomes from several lineages prevalent in the first wave to a dominance of the B.1.1.519 variant (defined by T478K, P681H, and T732A mutations in the spike protein) in the second wave. Conclusion This work contributes to a better understanding of the evolutionary dynamics and selective pressures that act at the genomic level, the prediction of more accurate variants of clinical significance, and a better comprehension of the molecular mechanisms driving the evolution of SARS-CoV-2 to improve vaccine and drug development.
... Since this first sequence, more than 14 million have been added to GISAID [3]. In Mexico, the first sequence of 29,849 bp from a 35-year-old patient was submitted to GISAID in March 2020 [5], with the average time from collection to report for the first 100 sequences reported in Mexico being 77 days [6]. To date, more than 80,000 sequences have been reported by multiple institutions in the country [3]. ...
Article
Full-text available
Objective: The aim of this work was to analyze the metadata of the SARS-CoV-2 sequences obtained from samples collected in Mexico from 2020 to 2022. Materials and Methods: Metadata of SARS-CoV-2 sequences from samples collected in Mexico up to 31 December 2022 was retrieved from GISAID and manually cured for interpretation. Results: As of December 2022, Mexican health authorities and the scientific community have sequenced up to 81,983 SARS-CoV-2 viral genomes deposited in GISAID, representing 1.1% of confirmed cases. The number of sequences obtained per state corresponded to the gross domestic product (GDP) of each state for the first (Mexico City) and the last (Tlaxcala). Approximately 25% of the sequences were obtained from CoViGen-Mex, an interdisciplinary initiative of health and scientific institutions to collect and sequence samples nationwide. The metadata showed a clear dominance of sequences retrieved by women. A similar variant distribution over time was found in Mexico and overseas, with the Omicron variant predominating. Finally, the age group with the highest representation in the sequences was adults aged 21 to 50 years, accounting for more than 50% of the total. Conclusions: Mexico presents diverse sociodemographic and economic characteristics. The COVID-19 pandemic has been and continues to be a challenge for collaboration across the country and around the world.
... In Mexico, the first case of COVID-19 was detected on February 27th, 2020 (Garcés-Ayala et al., 2020). Over the following 18 months, 3.5 millions confirmed cases and an overall mortality of 9% were reported for the country (Conacyt). ...
Article
Full-text available
Background The pandemic propagation of SARS-CoV-2 led to the adoption of a myriad of non-pharmacological interventions (NPIs, e.g., social distancing, mobility restrictions, gathering restrictions) in the Americas. Using national epidemiological data, here we report the impact of the layered adoption of multiple NPIs aimed at curving SARS-CoV-2 transmission in Yucatan State, Mexico. Methods. Data from suspected and laboratory confirmed COVID-19 cases during 2020 were analyzed by age groups and sex, clinical signs, and symptoms as well as outcome. The impact of NPIs was quantified using time-varying reproduction numbers (Rt) estimated as a time-series and by sectors of the city. Findings. A total of 69,602 suspected cases were reported, 39.3% were laboratory-confirmed. Men were hospitalized (60.2%), more severely ill (3% vs 1.9%) and more likely to die (62%) than women. Early in the outbreak, all sectors in Merida had Rt estimates above unity. Once all NPÍs were in place, Rt values were dramatically reduced below one, and in the last interval transmission estimates of Rt remained below one in all sectors. Interpretation. In the absence of a COVID-19 vaccination program, the combination and wide adherence of NPÍs led to a low and stable trend in SARS-oV-2 transmission that did not overwhelm the health sector. Our study reflects that a controlled and planned ease of restrictions to balance health, social and economic recovery resulted in a single wave of transmission that prolonged at low and stable levels. Funding. GVP received funding from Emory University via the MP3 Initiative.
... Primarily these are in-depth case reports on small datasets but demonstrate the utility of genomics combined with contact tracing . Here, we combine contact-tracing data from National Health Service (NHS) Test and Trace (T&T) for probable importation cases with genomes made available through the COVID- 19 Genomics UK (COG-UK) consortium 36 to characterise the known imported cases of SARS-CoV-2 into England and the effectiveness of 14-day quarantine on onwards transmission. ...
Article
Full-text available
Mitigation of SARS-CoV-2 transmission from international travel is a priority. We evaluated the effectiveness of travellers being required to quarantine for 14-days on return to England in Summer 2020. We identified 4,207 travel-related SARS-CoV-2 cases and their contacts, and identified 827 associated SARS-CoV-2 genomes. Overall, quarantine was associated with a lower rate of contacts, and the impact of quarantine was greatest in the 16–20 age-group. 186 SARS-CoV-2 genomes were sufficiently unique to identify travel-related clusters. Fewer genomically-linked cases were observed for index cases who returned from countries with quarantine requirement compared to countries with no quarantine requirement. This difference was explained by fewer importation events per identified genome for these cases, as opposed to fewer onward contacts per case. Overall, our study demonstrates that a 14-day quarantine period reduces, but does not completely eliminate, the onward transmission of imported cases, mainly by dissuading travel to countries with a quarantine requirement.
... The Covid-19 pandemic has placed epidemic modeling at the forefront of public policy-making around the world [4]. From this point of view, the international scientific interest in Covid-19 is of great proportions, as indicated by a large number of publications in specialized journals such as medicine, biology, mathematics, physics, such as, for example [7,10,11,13,18,19,26,30], among others. Therefore, by studying the dynamic behavior on the evolution of the SARS-COV2 virus, millions of lives could be saved, since the authorities can use this information to continue preparing and facing this crisis that has not yet ended in more convenient ways by counting with a priori information [1]. ...
Article
Full-text available
In this work we propose some mathematical models to simulate seasonality behavior of Covid-19 spread; a periodic transmission rate is added to SEIR, SEIRS, SEIRS with vaccination (SEIRSV) ode systems and the models are fitted to reported Covid infected historical data 2021 in Mexico. Numerical simulations reproduce the qualitative seasonality behavior of covid spread and provide an insight to develop strategies to prevent the diseases spread. Nearly all discussed approaches show the possible appearance of a fourth covid wave in Mexico at the end of 2021. Our results suggest that it is mandatory to consider seasonal factors when planing intervention strategies.
... Primarily these are in-depth case reports on small datasets but demonstrate the utility of genomics combined with contact tracing . Here, we combine contact-tracing data from National Health Service (NHS) Test and Trace (T&T) for probable importation cases with genomes made available through the COVID- 19 Genomics UK (COG-UK) consortium 36 to characterise the known imported cases of SARS-CoV-2 into England and the effectiveness of 14-day quarantine on onwards transmission. ...
Article
Full-text available
Mitigation of SARS-CoV-2 transmission from international travel is a priority. We evaluated the effectiveness of travellers being required to quarantine for 14-days on return to England in Summer 2020. We identified 4,207 travel-related SARS-CoV-2 cases and their contacts, and identified 827 associated SARS-CoV-2 genomes. Overall, quarantine was associated with a lower rate of contacts, and the impact of quarantine was greatest in the 16–20 age-group. 186 SARS-CoV-2 genomes were sufficiently unique to identify travel-related clusters. Fewer genomically-linked cases were observed for index cases who returned from countries with quarantine requirement compared to countries with no quarantine requirement. This difference was explained by fewer importation events per identified genome for these cases, as opposed to fewer onward contacts per case. Overall, our study demonstrates that a 14-day quarantine period reduces, but does not completely eliminate, the onward transmission of imported cases, mainly by dissuading travel to countries with a quarantine requirement.
Article
Full-text available
The use of phylogenetic tools could be key in making decisions in the management of epidemics. Phylogenetic reconstruction requires appropriate markers, which contain the necessary information and allow reconstructing the evolutionary history of the pathogen. For the study of SARS-Cov-2 at the international level, multiple complete genomes of the virus have been sequenced starting from isolates from several countries. This information, available in international databases, has facilitated phylogenomic studies. In the case of Cuba, technological capabilities do not allow complete genomes to be sequenced, which makes it necessary to evaluate the different SARS-Cov-2 genomic regions for their potential use as sources of information. This work describes an analysis, carried out at the beginning of the pandemic, of the genomic regions of SARS-Cov-2, to evaluate their possible use as phylogenetic markers. For this, sequences and public tools were used, taking into account their variability, tendency to saturation and presence of noise, in addition to evaluating their ability to reconstruct the same phylogenetic relationships as those obtained with the analysis of the entire genome. Due to the relatively low evolutionary rate of the virus, and the short time that has elapsed since the beginning of the transmission of SARS-Cov-2 in humans at the time of the study, it is observed that the variability in the individual genomic regions does not contribute the same level of information, that the complete genome, and that the length of the selected segment and the taxonomic sampling are decisive in the resolution capacity of the phylogenetic methods used.
Article
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is significantly impacting human lives, overburdening the healthcare system and weakening global economies. Plant-derived natural compounds are being largely tested for their efficacy against COVID-19 targets to combat SARS-CoV-2 infection. The SARS-CoV-2 Main protease (Mpro) is considered an appealing target because of its role in replication in host cells. We curated a set of 7809 natural compounds by combining the collections of five databases viz Dr Duke's Phytochemical and Ethnobotanical database, IMPPAT, PhytoHub, AromaDb and Zinc. We applied a rigorous computational approach to identify lead molecules from our curated compound set using docking, dynamic simulations, the free energy of binding and DFT calculations. Theaflavin and ginkgetin have emerged as better molecules with a similar inhibition profile in both SARS-CoV-2 and Omicron variants.
Chapter
This chapter introduces the resultant outcomes and predictions of SARS-CoV-2 genome sequencing. It begins with the structural features of the viral genome, which are the results of initial efforts of genome sequencing. It then deals with the revelations about the origin and phylogeny of the virus, highlighting the zoonotic transmission and possible animal reservoirs. In addition, the genomic variations found during genome sequencing have been discussed. For convenience, these have been divided according to the life cycle of the virus that occurs in different stages. Furthermore, the chapter focuses on promising druggable targets that have been discovered so far, due to the efforts of genome sequencing. Several targets have been discussed, with respect to their structure and mechanism of possible inhibition.
Chapter
The coronavirus disease 2019 (COVID-19) was identified as the cause of an outbreak of respiratory illness in Wuhan in 2019. Some of the antivirals presently being tried are known anti-HIV (combination of lopinavir and ritonavir) and the rejected anti-ebola virus (remdesivir) drugs. Others are chloroquine, hydroxychloroquine and azithromycin. Till date, there is no specific antiviral treatment that has proven effective in the management of the pandemic. The infected victims primarily rely on symptomatic treatments and supportive care. This COVID-19 outbreak has triggered researchers worldwide to embark on more high-quality researches, in addition to the preventive measures, to manage the public health emergency in both the short- and long-term. Membrane lipids like cholesterol, glycerophospholipids and sphingolipids play key role in modification of intracellular membrane structures for virus replication. This chapter discussed the roles of membrane lipids in coronavirus replication, and inhibition of lipids biosynthesis for possible management of coronavirus disease.
Article
Full-text available
Laboratory preparedness with quality-assured diagnostic assays is essential for controlling the current coronavirus disease (COVID-19) outbreak. We conducted an external quality assessment study with inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) samples to support clinical laboratories with a proficiency testing option for molecular assays. To analyse SARS-CoV-2 testing performance, we used an online questionnaire developed for the European Union project RECOVER to assess molecular testing capacities in clinical diagnostic laboratories.
Article
Full-text available
In December 2019, a cluster of patients with pneumonia of unknown cause was linked to a seafood wholesale market in Wuhan, China. A previously unknown betacoronavirus was discovered through the use of unbiased sequencing in samples from patients with pneumonia. Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed another clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily. Different from both MERS-CoV and SARS-CoV, 2019-nCoV is the seventh member of the family of coronaviruses that infect humans. Enhanced surveillance and further investigation are ongoing. (Funded by the National Key Research and Development Program of China and the National Major Project for Control and Prevention of Infectious Disease in China.).
Article
Full-text available
Background: A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of these patients. Methods: All patients with suspected 2019-nCoV were admitted to a designated hospital in Wuhan. We prospectively collected and analysed data on patients with laboratory-confirmed 2019-nCoV infection by real-time RT-PCR and next-generation sequencing. Data were obtained with standardised data collection forms shared by the International Severe Acute Respiratory and Emerging Infection Consortium from electronic medical records. Researchers also directly communicated with patients or their families to ascertain epidemiological and symptom data. Outcomes were also compared between patients who had been admitted to the intensive care unit (ICU) and those who had not. Findings: By Jan 2, 2020, 41 admitted hospital patients had been identified as having laboratory-confirmed 2019-nCoV infection. Most of the infected patients were men (30 [73%] of 41); less than half had underlying diseases (13 [32%]), including diabetes (eight [20%]), hypertension (six [15%]), and cardiovascular disease (six [15%]). Median age was 49·0 years (IQR 41·0-58·0). 27 (66%) of 41 patients had been exposed to Huanan seafood market. One family cluster was found. Common symptoms at onset of illness were fever (40 [98%] of 41 patients), cough (31 [76%]), and myalgia or fatigue (18 [44%]); less common symptoms were sputum production (11 [28%] of 39), headache (three [8%] of 38), haemoptysis (two [5%] of 39), and diarrhoea (one [3%] of 38). Dyspnoea developed in 22 (55%) of 40 patients (median time from illness onset to dyspnoea 8·0 days [IQR 5·0-13·0]). 26 (63%) of 41 patients had lymphopenia. All 41 patients had pneumonia with abnormal findings on chest CT. Complications included acute respiratory distress syndrome (12 [29%]), RNAaemia (six [15%]), acute cardiac injury (five [12%]) and secondary infection (four [10%]). 13 (32%) patients were admitted to an ICU and six (15%) died. Compared with non-ICU patients, ICU patients had higher plasma levels of IL2, IL7, IL10, GSCF, IP10, MCP1, MIP1A, and TNFα. Interpretation: The 2019-nCoV infection caused clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus and was associated with ICU admission and high mortality. Major gaps in our knowledge of the origin, epidemiology, duration of human transmission, and clinical spectrum of disease need fulfilment by future studies. Funding: Ministry of Science and Technology, Chinese Academy of Medical Sciences, National Natural Science Foundation of China, and Beijing Municipal Science and Technology Commission.
Article
Full-text available
Background The ongoing outbreak of the recently emerged novel coronavirus (2019-nCoV) poses a challenge for public health laboratories as virus isolates are unavailable while there is growing evidence that the outbreak is more widespread than initially thought, and international spread through travellers does already occur.AimWe aimed to develop and deploy robust diagnostic methodology for use in public health laboratory settings without having virus material available.Methods Here we present a validated diagnostic workflow for 2019-nCoV, its design relying on close genetic relatedness of 2019-nCoV with SARS coronavirus, making use of synthetic nucleic acid technology.ResultsThe workflow reliably detects 2019-nCoV, and further discriminates 2019-nCoV from SARS-CoV. Through coordination between academic and public laboratories, we confirmed assay exclusivity based on 297 original clinical specimens containing a full spectrum of human respiratory viruses. Control material is made available through European Virus Archive - Global (EVAg), a European Union infrastructure project.Conclusion The present study demonstrates the enormous response capacity achieved through coordination of academic and public laboratories in national and European research networks.
Article
Full-text available
We announce the release of an advanced version of the Molecular Evolutionary Genetics Analysis (MEGA) software, which currently contains facilities for building sequence alignments, inferring phylogenetic histories, and conducting molecular evolutionary analysis. In version 6.0, MEGA now enables the inference of timetrees, as it implements our RelTime method for estimating divergence times for all branching points in a phylogeny. A new Timetree Wizard in MEGA6 facilitates this timetree inference by providing a graphical user interface (GUI) to specify the phylogeny and calibration constraints step-by-step. This version also contains enhanced algorithms to search for the optimal trees under evolutionary criteria and implements a more advanced memory management that can double the size of sequence data sets to which MEGA can be applied. Both GUI and command-line versions of MEGA6 can be downloaded from www.megasoftware.net free of charge.
Article
Full-text available
The lion's share of bacteria in various environments cannot be cloned in the laboratory and thus cannot be sequenced using existing technologies. A major goal of single-cell genomics is to complement gene-centric metagenomic data with whole-genome assemblies of uncultivated organisms. Assembly of single-cell data is challenging because of highly non-uniform read coverage as well as elevated levels of sequencing errors and chimeric reads. We describe SPAdes, a new assembler for both single-cell and standard (multicell) assembly, and demonstrate that it improves on the recently released E+V-SC assembler (specialized for single-cell data) and on popular assemblers Velvet and SoapDeNovo (for multicell data). SPAdes generates single-cell assemblies, providing information about genomes of uncultivatable bacteria that vastly exceeds what may be obtained via traditional metagenomics studies. SPAdes is available online ( http://bioinf.spbau.ru/spades ). It is distributed as open source software.
Comunicado Técnico Diario Nuevo Coronavirus en el Mundo (COVID-19)
  • Salud Secretaria De
Secretaria de Salud (2020) Comunicado Técnico Diario Nuevo Coronavirus en el Mundo (COVID-19). 2020, March 20. https :// www.gob.mx/cms/uploa ds/attac hment /file/54259 9/Comun icado _Tecni co_Diari o_COVID -19_2020.03.20.pdf. Accessed 20 Mar 2020
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
  • V M Corman
  • O Landt
  • M Kaiser
  • R Molenkamp
  • A Meijer
  • Dkw Chu
  • T Bleicker
  • S Brünink
  • J Schneider
  • M L Schmidt
  • D Mulders
  • B L Haagmans
  • B Van Der Veer
  • S Van Den Brink
  • L Wijsman
  • G Goderski
  • J L Romette
  • J Ellis
  • M Zambon
  • M Peiris
  • H Goossens
  • C Reusken
  • Mpg Koopmans
  • C Drosten
  • VM Corman
Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, Bleicker T, Brünink S, Schneider J, Schmidt ML, Mulders D, Haagmans BL, van der Veer B, van den Brink S, Wijsman L, Goderski G, Romette JL, Ellis J, Zambon M, Peiris M, Goossens H, Reusken C, Koopmans MPG, Drosten C (2020) Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. https ://doi.org/10.2807/1560-7917.es.2020.25.3.20000 45
A novel coronavirus from patients with pneumonia in China
  • N Zhu
  • D Zhang
  • W Wang
  • X Li
  • B Yang
  • J Song